Zenas BioPharma, Inc. (ZBIO) Reports Q3 Loss of $5.02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq set for higher open as oil prices extend declines, midterm results awaited
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- Goldman data shows hedge funds cut leverage at fastest pace since March
Tweet
Share
E-mailGet Alerts ZBIO Hot Sheet
Join SI Premium – FREE
Zenas BioPharma, Inc. (NASDAQ: ZBIO) reported Q3 EPS of ($5.02).
For earnings history and earnings-related data on Zenas BioPharma, Inc. (ZBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top E-Commerce Stock Pick from BMO Capital Markets
- Core Molding Technologies, Inc. (CMT) Misses Q3 EPS by 3c
- StoneX Reiterates Buy Rating on Liberty Braves (BATRA)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
